Publications | Research impact

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

A 'hidden problem': Nature, prevalence and factors associated with sexual dysfunction in persons living with HIV/AIDS in Uganda.

Mutamba, BB; Rukundo, GZ; Sembajjwe, W; Nakasujja, N; Birabwa-Oketcho, H; Mpango, RS; KINYANDA, E;

2024

PloS one, (2024).19 3 10.1371/journal.pone.0295224.

Mendelian randomization studies on coronary artery disease: a systematic review and meta-analysis.

SILVA, S; FATUMO, S; NITSCH, D;

2024

Systematic reviews, (2024).13 1 10.1186/s13643-023-02442-8.

Human leukocyte antigen-DQA1*04:01 and rs2040406 variants are associated with elevated risk of childhood Burkitt lymphoma.

Liu, Z; Luo, Y; Kirimunda, S; Verboom, M; Onabajo, OO; Gouveia, MH; Ogwang, MD; Kerchan, P; Reynolds, SJ; Tenge, CN; Were, PA; Kuremu, RT; Wekesa, WN; Masalu, N; Kawira, E; Kinyera, T; Otim, I; Legason, ID; Nabalende, H; Dhudha, H; Ayers, LW; Bhatia, K; Goedert, JJ; Cole, N; Luo, W; ... Mbulaiteye, SM.

2024

Communications biology, (2024).7 1 10.1038/s42003-023-05701-5.

The Single-Dose Janssen Ad26.COV2.S COVID-19 Vaccine Elicited Robust and Persistent Anti-Spike IgG Antibody Responses in A 12-Month Ugandan Cohort.

SERWANGA, J; Kato, L; Ankunda, V; Kitabye, I; Namuyanja, A; Opio, S; Sembera, J; Baine, C; Katende, JS; Oluka, GK; Ejou, P; Kaleebu, P;

2024

Preprints.org (2024). 10.20944/preprints202401.0089.v1.

Correction: Effectiveness and cost-effectiveness of a transdiagnostic intervention for alcohol misuse and psychological distress in humanitarian settings: study protocol for a randomised controlled trial in Uganda.

VAN DER BOOR, CF; Taban, D; Tol, WA; Akellot, J; NEUMAN, M; WEISS, HA; GRECO, G; VASSALL, A; MAY, C; NADKARNI, A; KINYANDA, E; ROBERTS, B; Fuhr, DC;

2024

Trials, (2024).25 1 10.1186/s13063-024-08030-y.

Assessing COVID-19 vaccine roll-out in Uganda: a case study of uptake and associated factors among health care workers and older people.

BAHEMUKA, UM; Abaasa, A; Asaba, R; Ssemwanga, E; Muwanga, M; Nsereko, C; Nsubuga, D; Sande, S; Wajja, A; SEELEY, J; ELLIOTT, A; Ruzagira, E;

2024

Open Res Africa (2024). 10.12688/openresafrica.14719.1.

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies.

Ankunda, V; Katende, JS; Oluka, GK; Sembera, J; Baine, C; Odoch, G; Ejou, P; Kato, L; COVID-19 Immunoprofiling Team,; KALEEBU, P; Serwanga, J;

2024

Frontiers in immunology, (2024).15, 10.3389/fimmu.2024.1325387.

Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda.

Kimbugwe, G; Vatrinet, R; Mwanga, JA; Kakuru, R; Mpeirwe, D; Logoose, S; Opio, K; Kambale, M; SEELEY, J; Grais, RF; Marquer, C; KALEEBU, P; SSALI, A;

2024

Vaccine, (2024).42 12 10.1016/j.vaccine.2024.03.053.

Decentralising chronic disease management in sub-Saharan Africa: a protocol for the qualitative process evaluation of community-based integrated management of HIV, diabetes and hypertension in Tanzania and Uganda.

Van Hout, M-C; Akugizibwe, M; Shayo, EH; Namulundu, M; KASUJJA, FX; Namakoola, I; BIRUNGI, J; Okebe, J; Murdoch, J; Mfinanga, SG; Jaffar, S;

2024

BMJ open, (2024).14 3 10.1136/bmjopen-2023-078044.

Viruses associated with measles-like illnesses in Uganda.

Namuwulya, P; Ashraf, S; Niebel, M; Ssekagiri, A; Tushabe, P; Kakooza, P; Tong, L; Bukenya, H; Jerome, H; Davis, C; Birungi, M; Turyahabwe, I; Mugaga, A; Eliku, JP; Francis, A; Nakabazzi, L; Nsubuga, F; Katushabe, E; Kisakye, A; Ampeire, I; Nanteza, A; KALEEBU, P; Bakamutumaho, B; Nsamba, P; Kazibwe, A; ... THOMSON, EC.

2024

The Journal of infection, (2024).88 5 10.1016/j.jinf.2024.106148.